Comparative Real-World Outcomes of LifeStream and Viabahn VBX Balloon-Expandable Covered Stents for Iliac Artery Occlusive Disease

Imagine your body's plumbing system as a vast network of highways delivering life-giving fuel (blood) to every neighborhood. Sometimes, these highways get clogged with gunk called plaque, narrowing the lanes and making it hard for traffic to flow. This is what happens in a condition called peripheral artery disease, specifically when the big "interstate" arteries in the pelvis (the iliac arteries) get blocked. When the roads are too narrow, your legs might feel tired, crampy, or even hurt when you walk.

To fix these clogged roads, doctors often use a minimally invasive trick called endovascular therapy. Instead of opening up the whole body with a big knife, they thread a tiny, flexible tube through a small cut in the groin. Inside this tube, they carry a special "road-repair kit." Sometimes, they just blow up a balloon to squash the gunk flat. But for really tough, scarred, or broken roads, they need to leave something behind to hold the walls open permanently. This is where stents come in. Think of a stent as a tiny, expandable metal scaffold that acts like a permanent support beam, keeping the artery wide open so blood can rush through again.

Now, there's a twist: some of these scaffolds come with a built-in "tarp" or cover. These are called covered stents. Just like a tent protects you from the rain, a covered stent covers the inside of the artery to stop scar tissue from growing back through the metal bars and clogging the road again. Doctors have a few different brands of these covered stents to choose from, like picking between different models of high-tech scaffolding. But here's the big question: Does one brand work better than the other? Or are they all basically the same when it comes to keeping the highway clear? That's exactly what this study set out to find out.

---

The Great Stent Showdown: LifeStream vs. Viabahn VBX

In this real-world investigation, researchers from several hospitals in Japan decided to pit two popular covered stents against each other: the LifeStream and the Viabahn VBX. They looked back at the records of 226 patients who had these stents implanted to fix blocked iliac arteries between 2020 and 2025. It wasn't a lab experiment where they controlled every single variable; instead, it was a look at how these devices performed in the messy, complex reality of actual hospitals, where doctors choose the tool based on what they see and what they have available.

The researchers were particularly interested in a one-year follow-up. They wanted to know: Did the roads stay open? Did the patients need to go back for more repairs? Did anything go wrong during the surgery?

To make sure the comparison was fair, the scientists used a clever statistical trick called Inverse Probability of Treatment Weighting (IPTW). Imagine you have two groups of runners: one group is mostly older and has diabetes, while the other is younger and healthier. If you just compare their race times, it wouldn't be fair. IPTW is like giving the older runners a slight head start or adjusting the clock so that both groups look statistically identical before the race begins. This allowed the researchers to compare the stents as if the patients in both groups were twins, removing the bias of who got which stent.

The Results: A Dead Heat

After running the numbers, the study found something surprising: there was no clear winner.

When the researchers checked the data one year later, they found that both stents were incredibly effective at keeping the arteries open.

• LifeStream: About 97.7% of patients in this group stayed free from restenosis (the road getting clogged again).
• Viabahn VBX: About 95.5% of patients in this group stayed free from restenosis.

Statistically, this tiny difference wasn't significant. It's like two runners finishing a race in 10.01 seconds and 10.02 seconds; you can't really say one is faster than the other based on that split-second gap. The study also looked at other important outcomes:

• Need for more surgery (CD-TLR): Both groups were nearly identical, with over 96% of patients not needing a repeat procedure.
• Total blockage (Re-occlusion): The LifeStream group had a perfect 100% success rate, while the Viabahn group was at 97.8%. Again, no big difference.
• Surgery conversion: Neither group needed to switch to open surgery to fix the problem.
• Complications: Both groups had very few problems during the surgery (around 8-9%), and the types of issues (like small tears or bleeding) were similar.

The "What If" Questions

The researchers didn't just stop at the average results. They asked: "Maybe one stent is better for older people? Or for really long blockages? Or for patients with diabetes?" They ran special tests to see if the type of patient or the type of blockage changed the outcome.

The answer? Nope.
Whether the patient was over 75, had severe diabetes, had a completely blocked artery (CTO), or had very long blockages, neither stent showed a clear advantage over the other. The study suggests that the choice between LifeStream and Viabahn VBX probably doesn't depend on the specific details of the patient's disease.

The Fine Print: Why We Shouldn't Celebrate Too Early

While the results are great news for patients, the authors are very careful not to declare a "victory" for either brand. They point out a few reasons why we should treat these findings as a strong hint rather than a final rule:

1. Small Number of Events: Only 10 patients out of the 226 had their arteries clog up again. When you have such a small number of "failures," it's hard to be 100% sure that the two stents are truly equal. It's like flipping a coin 10 times and getting 6 heads and 4 tails; you can't be certain the coin is fair yet.
2. Missing Data: The study only had complete follow-up data for 163 patients (about 72%). Some people were lost to follow-up, perhaps because of the pandemic or other reasons, which might skew the results slightly.
3. Real-World Chaos: Since this wasn't a controlled experiment where doctors were forced to pick one stent, the choice was up to the individual surgeons. Even with the statistical "twin-making" trick, there might be hidden differences between the groups that the study couldn't see.
4. High-Tech Guidance: A huge number of these procedures used IVUS (a tiny ultrasound camera inside the artery) to guide the stent placement. This high-tech help likely made the results better than they would have been with just X-ray guidance. So, these great results might be partly thanks to the camera, not just the stent itself.

The Bottom Line

This study suggests that for patients with blocked iliac arteries, both the LifeStream and Viabahn VBX covered stents are excellent choices that perform almost identically over the first year. Neither one is clearly better at preventing clogs, avoiding repeat surgeries, or causing complications.

However, because the number of problems was small and the study wasn't a perfect experiment, the authors say these findings are "hypothesis-generating." In plain English: "It looks like they are the same, and that's a great starting point for a bigger, more perfect study to prove it once and for all." For now, doctors can feel confident that either tool will likely get the job done, and the choice might come down to what the surgeon is most comfortable with or what size fits the patient's specific anatomy.